EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

NAT10 and cytidine acetylation in mRNA: intersecting paths in development and disease

Cyrinne Achour, Shalini Oberdoerffer

Current Opinion in Genetics & Development · 2024-08 · 87 · 102207

DOI: 10.1016/j.gde.2024.102207 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Opinion in Genetics & Development, 2024-08. Verfasst von Cyrinne Achour und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Receptor Biology and Gene Expression, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA. Hauptthemen laut MEDLINE: Cytidine, RNA, Messenger. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, National Institutes of Health, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N4-acetylcytidine (ac4C) is an RNA modification that is catalyzed by the enzyme NAT10. Constitutively found in tRNA and rRNA, ac4C displays a dynamic presence in mRNA that is shaped by developmental and induced shifts in NAT10 levels. However, deciphering ac4C functions in mRNA has been hampered by its context-dependent influences in translation and the complexity of isolating effects on specific mRNAs from other NAT10 activities. Recent advances have begun to overcome these obstacles by leveraging natural variations in mRNA acetylation in cancer, developmental transitions, and immune responses. Here, we synthesize the current literature with a focus on nuances that may fuel the perception of cellular discrepancies toward the development of a cohesive model of ac4C function in mRNA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytidineRNA, MessengerHumansAcetylationN-Terminal Acetyltransferase EN-Terminal AcetyltransferasesNeoplasms

Substanzen

CytidineN-acetylcytidineN-Terminal Acetyltransferase EN-Terminal AcetyltransferasesNAT10 protein, humanRNA, Messenger

Autor:innen und Institutionen

  • Laboratory of Receptor Biology and Gene Expression, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA.
  • Laboratory of Receptor Biology and Gene Expression, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA. Electronic address: shalini.oberdoerffer@nih.gov.

Förderung

  • Intramural NIH HHS
  • National Institutes of Health
  • National Cancer Institute
  • Center for Cancer Research

Zitieren

APA

Achour, C., & Oberdoerffer, S. (2024). NAT10 and cytidine acetylation in mRNA: intersecting paths in development and disease. Current Opinion in Genetics & Development, 87, 102207. https://doi.org/10.1016/j.gde.2024.102207

Vancouver

Achour C, Oberdoerffer S. NAT10 and cytidine acetylation in mRNA: intersecting paths in development and disease. Current Opinion in Genetics & Development. 2024;87:102207. doi:10.1016/j.gde.2024.102207

BibTeX
@article{Achour2024,
  author = {Achour, Cyrinne and Oberdoerffer, Shalini},
  title = {NAT10 and cytidine acetylation in mRNA: intersecting paths in development and disease},
  journal = {Current Opinion in Genetics & Development},
  year = {2024},
  volume = {87},
  pages = {102207},
  doi = {10.1016/j.gde.2024.102207}
}
Kostenlos starten →